comparemela.com
  1. Home
  2. Live Updates
  3. Eupraxia Pharmaceuticals Announces New Positive Data - Breaking News

Latest Breaking News On - Eupraxia pharmaceuticals announces new positive data - Page 1 : comparemela.com

Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals.

United statesEupraxia diffuspheretmJames helliwellEupraxia pharmaceuticals announces new positive dataEupraxia pharmaceuticals incAmerican gastroenterological associationPharmaceuticals announces new positive dataEupraxia pharmaceuticalsChief executive officerClinical dataSecond cohortsPeak eosinophil countsEosinophilic esophagitis histology scoring systemThird cohortRegarding forward looking statementsAlthough eupraxia

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.